Standard BioTools Inc (NAS:LAB)
$ 1.86 0.02 (1.09%) Market Cap: 688.98 Mil Enterprise Value: 318.60 Mil PE Ratio: 0 PB Ratio: 1.23 GF Score: 75/100

Fluidigm Corp at UBS Global Healthcare Virtual Conference Transcript

May 25, 2021 / 06:00PM GMT
Release Date Price: $5.56 (-3.47%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Welcome. Dan Brennan on Day 2 of our Global Healthcare Conference for UBS. Really pleased to be joined with me here at 2:00 p.m. virtual presentation slot with Chris Linthwaite, CEO of Fluidigm. We might be having Vikram, CFO, join as well. We'll hear from them in a moment. But nonetheless, having Chris on stage with me, will be terrific, particularly following their event yesterday, their Investor Day and they're hosting, I believe, a user or a customer group meeting today. So maybe with that introduction, Chris, welcome.

Stephen Christopher Linthwaite
Fluidigm Corporation - President, CEO & Director

Thanks, Dan. I want just to thank you again for you and UBS for including us in your health care conference.

Questions & Answers

Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Awesome. So series of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot